Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2022 2
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes.
Aguilera X, Hormazábal J, Vial C, Cortes LJ, González C, Rubilar P, Apablaza M, Ramírez-Santana M, Icaza G, Nuñez-Franz L, Castillo-Laborde C, Ramírez-Riffo C, Pérez C, Quezada-Gate R, Said M, Vial P. Aguilera X, et al. Among authors: said m. Vaccines (Basel). 2022 Jun 30;10(7):1051. doi: 10.3390/vaccines10071051. Vaccines (Basel). 2022. PMID: 35891215 Free PMC article.
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020-2022.
Núñez-Franz L, Ramírez-Santana M, Rubilar P, Vial C, Apablaza M, González C, Said M, Olivares K, Cortés LJ, Hormazábal J, Canales L, Vial P, Icaza G, Quezada-Gaete R, Aguilera X. Núñez-Franz L, et al. Among authors: said m. Viruses. 2023 Jan 10;15(1):201. doi: 10.3390/v15010201. Viruses. 2023. PMID: 36680241 Free PMC article.
Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile.
Aguilera X, González C, Apablaza M, Rubilar P, Icaza G, Ramírez-Santana M, Pérez C, Cortes LJ, Núñez-Franz L, Quezada-Gaete R, Castillo-Laborde C, Correa J, Said M, Hormazábal J, Vial C, Vial P. Aguilera X, et al. Among authors: said m. Vaccines (Basel). 2022 Jun 23;10(7):1002. doi: 10.3390/vaccines10071002. Vaccines (Basel). 2022. PMID: 35891166 Free PMC article.
Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study.
Hormazábal J, Nuñez-Franz L, Rubilar P, Apablaza M, Vial C, Cortés LJ, González N, Vial P, Said M, González C, Olivares K, Aguilera X, Ramírez-Santana M. Hormazábal J, et al. Among authors: said m. Vaccine X. 2023 Aug 26;15:100372. doi: 10.1016/j.jvacx.2023.100372. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37693843 Free PMC article.